27.09.2010 14:21:00
|
Humana’s RightSourceRx Ranks Highest Two Years in a Row in "Prescription Delivery” Category of J.D. Power And Associates Study
Humana Inc. (NYSE: HUM) announced today that RightSourceRxSM, the home-delivery pharmacy for Humana Pharmacy SolutionsSM, a division of Humana Inc., has received the highest national ranking in the "Prescription Delivery” category among mail-order pharmacies in the J.D. Power and Associates 2010 National Pharmacy StudySM. Humana’s RightSourceRx pharmacy also ranks above the industry average in other key factors of the study including customer service, cost competitiveness and prescription ordering.
"We see every prescription order as an opportunity to provide perfect service for our members, and to help them achieve lifelong well-being,” said William Fleming, vice president, Humana Pharmacy Solutions. "Ranking highest in the mail-order prescription delivery category demonstrates our commitment to deliver our members’ prescriptions with accuracy and speed.”
Humana RightSourceRx customers have 24/7 access to licensed pharmacists who offer an easy, integrated ordering process, and monthly counseling by a nurse specifically trained in the member’s given condition and medication for any issues or concerns about medications.
The 2010 National Pharmacy Study is based on the responses of mail-order pharmacy customers who filled a new prescription or refilled a prescription during the three months prior to the J.D. Power and Associates survey period. Four factors are measured in the mail-order segment of the pharmacy study:
- Cost competitiveness
- Prescription delivery
- Prescription ordering
- Customer service
About Humana Pharmacy Solutions
Humana Pharmacy SolutionsSM (HPS), a division of Humana Inc., manages traditional pharmacy benefits with member-focused strategies to yield savings in pharmacy and total health expense. Providing prescription coverage for both individuals and groups, Humana strives to give members access to the medicine they need while offering guidance on clinically proven, therapeutically equivalent drugs that bring better value to the member and the customer.
About Humana
Humana Inc., headquartered in Louisville, Kentucky, is one of the nation’s largest publicly traded health and supplemental benefits companies, with approximately 10.3 million medical members and approximately 7.3 million specialty-benefit members.
Humana is a full-service benefits-solutions company, offering a wide array of health and supplementary benefit plans for employer groups, government programs and individuals.
Over its 49-year history, Humana has consistently seized opportunities to meet changing customer needs. Today, the company is a leader in consumer engagement, providing guidance that leads to lower costs and a better health plan experience throughout its diversified customer portfolio.
More information regarding Humana is available to investors via the Investor Relations page of the company’s Web site at http://www.humana.com, including copies of:
- Annual reports to stockholders
- Securities and Exchange Commission filings
- Most recent investor conference presentations
- Quarterly earnings news releases
- Replays of most recent earnings release conference calls
- Calendar of events (includes upcoming earnings conference call dates and times, as well as planned interaction with research analysts and institutional investors)
- Corporate Governance Information
About J.D. Power and Associates
J.D. Power and Associates is a global marketing information services company operating in key business sectors, including market research, forecasting, performance improvement, training and customer satisfaction. The company’s quality and satisfaction measures are based on responses from millions of consumers annually. For more information on cell phone ratings, car reviews, health insurance and more, please visit JDPower.com. J.D. Power and Associates is a business unit of The McGraw-Hill Companies.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Humana Inc.mehr Nachrichten
29.11.24 |
S&P 500-Wert Humana-Aktie: So viel hätten Anleger an einem Humana-Investment von vor einem Jahr verloren (finanzen.at) | |
22.11.24 |
S&P 500-Titel Humana-Aktie: So viel hätten Anleger mit einem Investment in Humana von vor 10 Jahren verdient (finanzen.at) | |
20.11.24 |
Börsianer in New York warten auf Impulse: S&P 500 notiert zum Ende des Mittwochshandels um seinen Schlusskurs vom Montag (finanzen.at) | |
20.11.24 |
Mittwochshandel in New York: S&P 500 fällt nachmittags zurück (finanzen.at) | |
20.11.24 |
Schwacher Handel: S&P 500 präsentiert sich mittags leichter (finanzen.at) | |
20.11.24 |
Verluste in New York: S&P 500 zeigt sich zum Start leichter (finanzen.at) | |
15.11.24 |
S&P 500-Papier Humana-Aktie: So viel hätten Anleger mit einem Investment in Humana von vor 5 Jahren verloren (finanzen.at) | |
14.11.24 |
Schwache Performance in New York: S&P 500 zeigt sich zum Start des Donnerstagshandels leichter (finanzen.at) |
Analysen zu Humana Inc.mehr Analysen
Aktien in diesem Artikel
Humana Inc. | 280,70 | 0,07% |
Indizes in diesem Artikel
S&P 500 | 6 032,38 | 0,56% |